Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection.

Chetchotisakd P, Anunnatsiri S, Nanagara R, Nithichanon A, Lertmemongkolchai G.

J Immunol Res. 2018 Dec 30;2018:6473629. doi: 10.1155/2018/6473629. eCollection 2018.

2.

Glibenclamide Reduces Primary Human Monocyte Functions Against Tuberculosis Infection by Enhancing M2 Polarization.

Kewcharoenwong C, Prabowo SA, Bancroft GJ, Fletcher HA, Lertmemongkolchai G.

Front Immunol. 2018 Sep 19;9:2109. doi: 10.3389/fimmu.2018.02109. eCollection 2018.

3.

A Rapid Immunochromatography Test Based on Hcp1 Is a Potential Point-of-Care Test for Serological Diagnosis of Melioidosis.

Phokrai P, Karoonboonyanan W, Thanapattarapairoj N, Promkong C, Dulsuk A, Koosakulnirand S, Canovali S, Indrawattana N, Jutrakul Y, Wuthiekanun V, Limmathurotsakul D, Brett PJ, Burtnick MN, Lertmemongkolchai G, Chantratita N.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00346-18. doi: 10.1128/JCM.00346-18. Print 2018 Aug.

4.

Melioidosis in Thailand: Present and Future.

Hinjoy S, Hantrakun V, Kongyu S, Kaewrakmuk J, Wangrangsimakul T, Jitsuronk S, Saengchun W, Bhengsri S, Akarachotpong T, Thamthitiwat S, Sangwichian O, Anunnatsiri S, Sermswan RW, Lertmemongkolchai G, Tharinjaroen CS, Preechasuth K, Udpaun R, Chuensombut P, Waranyasirikul N, Anudit C, Narenpitak S, Jutrakul Y, Teparrukkul P, Teerawattanasook N, Thanvisej K, Suphan A, Sukbut P, Ploddi K, Sirichotirat P, Chiewchanyon B, Rukseree K, Hongsuwan M, Wongsuwan G, Sunthornsut P, Wuthiekanun V, Sachaphimukh S, Wannapinij P, Chierakul W, Chewapreecha C, Thaipadungpanit J, Chantratita N, Korbsrisate S, Taunyok A, Dunachie S, Palittapongarnpim P, Sirisinha S, Kitphati R, Iamsirithaworn S, Chaowagul W, Chetchotisak P, Whistler T, Wongratanacheewin S, Limmathurotsakul D.

Trop Med Infect Dis. 2018;3(2):38. doi: 10.3390/tropicalmed3020038. Epub 2018 Apr 8.

5.

Immune Control of Burkholderia pseudomallei--Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes.

Nithichanon A, Rinchai D, Buddhisa S, Saenmuang P, Kewcharoenwong C, Kessler B, Khaenam P, Chetchotisakd P, Maillere B, Robinson J, Reynolds CJ, Boyton RJ, Altmann DM, Lertmemongkolchai G.

Front Immunol. 2018 Mar 20;9:484. doi: 10.3389/fimmu.2018.00484. eCollection 2018.

6.

Designing Probes for Immunodiagnostics: Structural Insights into an Epitope Targeting Burkholderia Infections.

Capelli R, Matterazzo E, Amabili M, Peri C, Gori A, Gagni P, Chiari M, Lertmemongkolchai G, Cretich M, Bolognesi M, Colombo G, Gourlay LJ.

ACS Infect Dis. 2017 Oct 13;3(10):736-743. doi: 10.1021/acsinfecdis.7b00080. Epub 2017 Jul 21.

PMID:
28707874
7.

A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines.

Wada Y, Nithichanon A, Nobusawa E, Moise L, Martin WD, Yamamoto N, Terahara K, Hagiwara H, Odagiri T, Tashiro M, Lertmemongkolchai G, Takeyama H, Groot AS, Ato M, Takahashi Y.

Sci Rep. 2017 Apr 28;7(1):1283. doi: 10.1038/s41598-017-01372-5.

8.

A proteasome inhibitor produced by Burkholderia pseudomallei modulates intracellular growth.

Wagley S, Vanaporn M, Rinchai D, Conejero L, Lertmemongkolchai G, Bancroft GJ, Titball RW.

Microb Pathog. 2017 Jun;107:175-180. doi: 10.1016/j.micpath.2017.03.015. Epub 2017 Mar 18.

9.

Interleukin 10 inhibits pro-inflammatory cytokine responses and killing of Burkholderia pseudomallei.

Kessler B, Rinchai D, Kewcharoenwong C, Nithichanon A, Biggart R, Hawrylowicz CM, Bancroft GJ, Lertmemongkolchai G.

Sci Rep. 2017 Feb 20;7:42791. doi: 10.1038/srep42791.

10.

Boosting of post-exposure human T-cell and B-cell recall responses in vivo by Burkholderia pseudomallei-related proteins.

Nithichanon A, Gourlay LJ, Bancroft GJ, Ato M, Takahashi Y, Lertmemongkolchai G.

Immunology. 2017 May;151(1):98-109. doi: 10.1111/imm.12709. Epub 2017 Feb 9.

11.

Glibenclamide impairs responses of neutrophils against Burkholderia pseudomallei by reduction of intracellular glutathione.

Kewcharoenwong C, Rinchai D, Nithichanon A, Bancroft GJ, Ato M, Lertmemongkolchai G.

Sci Rep. 2016 Oct 7;6:34794. doi: 10.1038/srep34794.

12.

Analyses of the Distribution Patterns of Burkholderia pseudomallei and Associated Phages in Soil Samples in Thailand Suggest That Phage Presence Reduces the Frequency of Bacterial Isolation.

Withatanung P, Chantratita N, Muangsombut V, Saiprom N, Lertmemongkolchai G, Klumpp J, Clokie MR, Galyov EE, Korbsrisate S.

PLoS Negl Trop Dis. 2016 Sep 26;10(9):e0005005. doi: 10.1371/journal.pntd.0005005. eCollection 2016 Sep.

13.

Flexible vs Rigid Epitope Conformations for Diagnostic- and Vaccine-Oriented Applications: Novel Insights from the Burkholderia pseudomallei BPSL2765 Pal3 Epitope.

Gori A, Peri C, Quilici G, Nithichanon A, Gaudesi D, Longhi R, Gourlay L, Bolognesi M, Lertmemongkolchai G, Musco G, Colombo G.

ACS Infect Dis. 2016 Mar 11;2(3):221-30. doi: 10.1021/acsinfecdis.5b00118. Epub 2016 Jan 11.

PMID:
27623032
14.

Cryptococcosis in Anti-Interferon-Gamma Autoantibody-Positive Patients: a Different Clinical Manifestation from HIV-Infected Patients.

Chetchotisakd P, Anunnatsiri S, Nithichanon A, Lertmemongkolchai G.

Jpn J Infect Dis. 2017 Jan 24;70(1):69-74. doi: 10.7883/yoken.JJID.2015.340. Epub 2016 May 9.

15.

BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot Data.

Boelen L, O'Neill PK, Quigley KJ, Reynolds CJ, Maillere B, Robinson JH, Lertmemongkolchai G, Altmann DM, Boyton RJ, Asquith B.

PLoS Comput Biol. 2016 Mar 8;12(3):e1004796. doi: 10.1371/journal.pcbi.1004796. eCollection 2016 Mar.

16.

The Blood Transcriptome of Experimental Melioidosis Reflects Disease Severity and Shows Considerable Similarity with the Human Disease.

Conejero L, Potempa K, Graham CM, Spink N, Blankley S, Salguero FJ, Pankla-Sranujit R, Khaenam P, Banchereau JF, Pascual V, Chaussabel D, Lertmemongkolchai G, O'Garra A, Bancroft GJ.

J Immunol. 2015 Oct 1;195(7):3248-3261. doi: 10.4049/jimmunol.1500641. Epub 2015 Aug 26.

17.

Macroautophagy is essential for killing of intracellular Burkholderia pseudomallei in human neutrophils.

Rinchai D, Riyapa D, Buddhisa S, Utispan K, Titball RW, Stevens MP, Stevens JM, Ogawa M, Tanida I, Koike M, Uchiyama Y, Ato M, Lertmemongkolchai G.

Autophagy. 2015;11(5):748-55. doi: 10.1080/15548627.2015.1040969.

18.

T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis.

Reynolds C, Goudet A, Jenjaroen K, Sumonwiriya M, Rinchai D, Musson J, Overbeek S, Makinde J, Quigley K, Manji J, Spink N, Yos P, Wuthiekanun V, Bancroft G, Robinson J, Lertmemongkolchai G, Dunachie S, Maillere B, Holden M, Altmann D, Boyton R.

J Immunol. 2015 May 15;194(10):4814-24. doi: 10.4049/jimmunol.1402862. Epub 2015 Apr 10.

19.

Increased abundance of ADAM9 transcripts in the blood is associated with tissue damage.

Rinchai D, Kewcharoenwong C, Kessler B, Lertmemongkolchai G, Chaussabel D.

Version 2. F1000Res. 2015 Apr 9 [revised 2016 Jan 1];4:89. doi: 10.12688/f1000research.6241.2. eCollection 2015.

20.

Systematic mutagenesis of genes encoding predicted autotransported proteins of Burkholderia pseudomallei identifies factors mediating virulence in mice, net intracellular replication and a novel protein conferring serum resistance.

Lazar Adler NR, Stevens MP, Dean RE, Saint RJ, Pankhania D, Prior JL, Atkins TP, Kessler B, Nithichanon A, Lertmemongkolchai G, Galyov EE.

PLoS One. 2015 Apr 1;10(4):e0121271. doi: 10.1371/journal.pone.0121271. eCollection 2015.

21.

Programmed death ligand 1 on Burkholderia pseudomallei-infected human polymorphonuclear neutrophils impairs T cell functions.

Buddhisa S, Rinchai D, Ato M, Bancroft GJ, Lertmemongkolchai G.

J Immunol. 2015 May 1;194(9):4413-21. doi: 10.4049/jimmunol.1402417. Epub 2015 Mar 23.

22.

From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK.

Gourlay LJ, Thomas RJ, Peri C, Conchillo-Solé O, Ferrer-Navarro M, Nithichanon A, Vila J, Daura X, Lertmemongkolchai G, Titball R, Colombo G, Bolognesi M.

FEBS J. 2015 Apr;282(7):1319-33. doi: 10.1111/febs.13223. Epub 2015 Feb 23.

23.

Melioidosis diagnostic workshop, 2013.

Hoffmaster AR, AuCoin D, Baccam P, Baggett HC, Baird R, Bhengsri S, Blaney DD, Brett PJ, Brooks TJ, Brown KA, Chantratita N, Cheng AC, Dance DA, Decuypere S, Defenbaugh D, Gee JE, Houghton R, Jorakate P, Lertmemongkolchai G, Limmathurotsakul D, Merlin TL, Mukhopadhyay C, Norton R, Peacock SJ, Rolim DB, Simpson AJ, Steinmetz I, Stoddard RA, Stokes MM, Sue D, Tuanyok A, Whistler T, Wuthiekanun V, Walke HT.

Emerg Infect Dis. 2015 Feb;21(2). doi: 10.3201/eid2102.141045.

24.

Structure-based design of a B cell antigen from B. pseudomallei.

Gaudesi D, Peri C, Quilici G, Gori A, Ferrer-Navarro M, Conchillo-Solé O, Thomas R, Nithichanon A, Lertmemongkolchai G, Titball R, Daura X, Colombo G, Musco G.

ACS Chem Biol. 2015 Mar 20;10(3):803-12. doi: 10.1021/cb500831y. Epub 2014 Dec 22.

PMID:
25495888
25.

Effect of host factors on neutrophil functions in response to Burkholderia pseudomallei in healthy Thai subjects.

Saengmuang P, Kewcharoenwong C, Tippayawat P, Nithichanon A, Buddhisa S, Lertmemongkolchai G.

Jpn J Infect Dis. 2014;67(6):436-40.

26.

CD4+ T cell epitopes of FliC conserved between strains of Burkholderia: implications for vaccines against melioidosis and cepacia complex in cystic fibrosis.

Musson JA, Reynolds CJ, Rinchai D, Nithichanon A, Khaenam P, Favry E, Spink N, Chu KK, De Soyza A, Bancroft GJ, Lertmemongkolchai G, Maillere B, Boyton RJ, Altmann DM, Robinson JH.

J Immunol. 2014 Dec 15;193(12):6041-9. doi: 10.4049/jimmunol.1402273. Epub 2014 Nov 12.

27.

Development of an open-heart intraoperative risk scoring model for predicting a prolonged intensive care unit stay.

Tribuddharat S, Sathitkarnmanee T, Ngamsangsirisup K, Charuluxananan S, Hurst CP, Silarat S, Lertmemongkolchai G.

Biomed Res Int. 2014;2014:158051. doi: 10.1155/2014/158051. Epub 2014 Apr 10.

28.

1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3⁺ regulatory T cells through preferential expansion and usage of interleukin-2.

Chambers ES, Suwannasaen D, Mann EH, Urry Z, Richards DF, Lertmemongkolchai G, Hawrylowicz CM.

Immunology. 2014 Sep;143(1):52-60. doi: 10.1111/imm.12289.

29.

A transcriptomic reporter assay employing neutrophils to measure immunogenic activity of septic patients' plasma.

Khaenam P, Rinchai D, Altman MC, Chiche L, Buddhisa S, Kewcharoenwong C, Suwannasaen D, Mason M, Whalen E, Presnell S, Susaengrat W, O'Brien K, Nguyen QA, Gersuk V, Linsley PS, Lertmemongkolchai G, Chaussabel D.

J Transl Med. 2014 Mar 11;12:65. doi: 10.1186/1479-5876-12-65.

30.

Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection.

Kewcharoenwong C, Rinchai D, Utispan K, Suwannasaen D, Bancroft GJ, Ato M, Lertmemongkolchai G.

Sci Rep. 2013 Nov 28;3:3363. doi: 10.1038/srep03363.

31.

Exploiting the Burkholderia pseudomallei acute phase antigen BPSL2765 for structure-based epitope discovery/design in structural vaccinology.

Gourlay LJ, Peri C, Ferrer-Navarro M, Conchillo-Solé O, Gori A, Rinchai D, Thomas RJ, Champion OL, Michell SL, Kewcharoenwong C, Nithichanon A, Lassaux P, Perletti L, Longhi R, Lertmemongkolchai G, Titball RW, Daura X, Colombo G, Bolognesi M.

Chem Biol. 2013 Sep 19;20(9):1147-56. doi: 10.1016/j.chembiol.2013.07.010. Epub 2013 Aug 29.

32.

A structure-based strategy for epitope discovery in Burkholderia pseudomallei OppA antigen.

Lassaux P, Peri C, Ferrer-Navarro M, Gourlay LJ, Gori A, Conchillo-Solé O, Rinchai D, Lertmemongkolchai G, Longhi R, Daura X, Colombo G, Bolognesi M.

Structure. 2013 Jan 8;21(1):167-175. doi: 10.1016/j.str.2012.10.005. Epub 2012 Nov 15.

33.

Production of interleukin-27 by human neutrophils regulates their function during bacterial infection.

Rinchai D, Khaenam P, Kewcharoenwong C, Buddhisa S, Pankla R, Chaussabel D, Bancroft GJ, Lertmemongkolchai G.

Eur J Immunol. 2012 Dec;42(12):3280-90. doi: 10.1002/eji.201242526. Epub 2012 Oct 25.

34.

Neutrophil extracellular traps exhibit antibacterial activity against burkholderia pseudomallei and are influenced by bacterial and host factors.

Riyapa D, Buddhisa S, Korbsrisate S, Cuccui J, Wren BW, Stevens MP, Ato M, Lertmemongkolchai G.

Infect Immun. 2012 Nov;80(11):3921-9. doi: 10.1128/IAI.00806-12. Epub 2012 Aug 27.

35.

Burkholderia pseudomallei-induced cell fusion in U937 macrophages can be inhibited by monoclonal antibodies against host cell surface molecules.

Suparak S, Muangsombut V, Riyapa D, Stevens JM, Stevens MP, Lertmemongkolchai G, Korbsrisate S.

Microbes Infect. 2011 Nov;13(12-13):1006-11. doi: 10.1016/j.micinf.2011.06.007. Epub 2011 Jul 6.

PMID:
21784167
36.

Superoxide dismutase C is required for intracellular survival and virulence of Burkholderia pseudomallei.

Vanaporn M, Wand M, Michell SL, Sarkar-Tyson M, Ireland P, Goldman S, Kewcharoenwong C, Rinchai D, Lertmemongkolchai G, Titball RW.

Microbiology. 2011 Aug;157(Pt 8):2392-400. doi: 10.1099/mic.0.050823-0. Epub 2011 Jun 9.

PMID:
21659326
37.

Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis.

Suwannasaen D, Mahawantung J, Chaowagul W, Limmathurotsakul D, Felgner PL, Davies H, Bancroft GJ, Titball RW, Lertmemongkolchai G.

J Infect Dis. 2011 Apr 1;203(7):1002-11. doi: 10.1093/infdis/jiq142. Epub 2011 Feb 7.

38.

CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.

Chu KK, Tippayawat P, Walker NJ, Harding SV, Atkins HS, Maillere B, Bancroft GJ, Lertmemongkolchai G, Altmann DM.

Eur J Immunol. 2011 Jan;41(1):107-15. doi: 10.1002/eji.201040881. Epub 2010 Dec 3.

39.

Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro.

Tippayawat P, Pinsiri M, Rinchai D, Riyapa D, Romphruk A, Gan YH, Houghton RL, Felgner PL, Titball RW, Stevens MP, Galyov EE, Bancroft GJ, Lertmemongkolchai G.

Infect Immun. 2011 Jan;79(1):305-13. doi: 10.1128/IAI.00803-10. Epub 2010 Nov 1.

40.

Bystander T cells in human immune responses to dengue antigens.

Suwannasaen D, Romphruk A, Leelayuwat C, Lertmemongkolchai G.

BMC Immunol. 2010 Sep 20;11:47. doi: 10.1186/1471-2172-11-47.

41.

Effect of acidic pH on the invasion efficiency and the type III secretion system of Burkholderia thailandensis.

Jitprasutwit S, Thaewpia W, Muangsombut V, Lulitanond A, Leelayuwat C, Lertmemongkolchai G, Korbsrisate S.

J Microbiol. 2010 Aug;48(4):526-32. doi: 10.1007/s12275-010-0078-x. Epub 2010 Aug 20.

PMID:
20799096
42.

Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis.

Pankla R, Buddhisa S, Berry M, Blankenship DM, Bancroft GJ, Banchereau J, Lertmemongkolchai G, Chaussabel D.

Genome Biol. 2009;10(11):R127. doi: 10.1186/gb-2009-10-11-r127. Epub 2009 Nov 10.

43.

A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens.

Felgner PL, Kayala MA, Vigil A, Burk C, Nakajima-Sasaki R, Pablo J, Molina DM, Hirst S, Chew JS, Wang D, Tan G, Duffield M, Yang R, Neel J, Chantratita N, Bancroft G, Lertmemongkolchai G, Davies DH, Baldi P, Peacock S, Titball RW.

Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13499-504. doi: 10.1073/pnas.0812080106. Epub 2009 Jul 28.

44.

A genetic programming approach for Burkholderia pseudomallei diagnostic pattern discovery.

Yang ZR, Lertmemongkolchai G, Tan G, Felgner PL, Titball R.

Bioinformatics. 2009 Sep 1;25(17):2256-62. doi: 10.1093/bioinformatics/btp390. Epub 2009 Jun 26.

45.

Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei.

Tippayawat P, Saenwongsa W, Mahawantung J, Suwannasaen D, Chetchotisakd P, Limmathurotsakul D, Peacock SJ, Felgner PL, Atkins HS, Titball RW, Bancroft GJ, Lertmemongkolchai G.

PLoS Negl Trop Dis. 2009;3(4):e407. doi: 10.1371/journal.pntd.0000407. Epub 2009 Apr 7.

46.

Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects.

Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G.

Infect Immun. 2009 Jan;77(1):456-63. doi: 10.1128/IAI.00503-08. Epub 2008 Oct 27.

47.

Development of real-time PCR assays and evaluation of their potential use for rapid detection of Burkholderia pseudomallei in clinical blood specimens.

Supaprom C, Wang D, Leelayuwat C, Thaewpia W, Susaengrat W, Koh V, Ooi EE, Lertmemongkolchai G, Liu Y.

J Clin Microbiol. 2007 Sep;45(9):2894-901. Epub 2007 Jul 18.

48.

Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei.

Rowland CA, Lertmemongkolchai G, Bancroft A, Haque A, Lever MS, Griffin KF, Jackson MC, Nelson M, O'Garra A, Grencis R, Bancroft GJ, Lukaszewski RA.

Infect Immun. 2006 Sep;74(9):5333-40.

49.

Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection.

Haque A, Easton A, Smith D, O'Garra A, Van Rooijen N, Lertmemongkolchai G, Titball RW, Bancroft GJ.

J Infect Dis. 2006 Feb 1;193(3):370-9. Epub 2005 Dec 27.

PMID:
16388484
50.

The Burkholderia pseudomallei RpoE (AlgU) operon is involved in environmental stress tolerance and biofilm formation.

Korbsrisate S, Vanaporn M, Kerdsuk P, Kespichayawattana W, Vattanaviboon P, Kiatpapan P, Lertmemongkolchai G.

FEMS Microbiol Lett. 2005 Nov 15;252(2):243-9. Epub 2005 Sep 15.

Supplemental Content

Loading ...
Support Center